Forget Moderna: This Biotech Juggernaut Is Rising Fast
A biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
A beginner guide explaining what altcoins are, their roles in crypto ecosystems, and how novices can evaluate them.
5,854 articlesA biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
Workday is set to report Q1 earnings after the close tonight, the first quarter under its returning CEO. Analysts foc...
Two tech giants stand out for investors seeking value in megacap stocks. This guide breaks down strengths, risks, and...
A bitcoin billionaire takes a front-row seat to a Starship Mars flyby, setting off a ripple of questions about crypto...
A bold AI experiment in Argentina aimed at reshaping public policy stumbled on human error and bad data. The fallout ...
AI-driven research is producing fake references at scale, threatening the reliability of published knowledge. The fal...
The billionaire bill gates' foundation recently remade its public equity lineup, selling its Microsoft stake and conc...
As Zoom prepares for 2026, investors want to know how the company will grow revenue, expand margins, and win with AI....
Zscaler is set to report Q3 after the close on May 28, 2026, with analysts eyeing ARR growth, AI monetization progres...
An activist investor’s purchase often signals interest in a company’s next chapter. Read how Edward Garden’s stake co...
The Las Vegas Strip bid farewell to a family-driven dining concept after almost four years. This article breaks down ...
Doximity sits at a crossroads: a robust physician network with multiple monetization channels, yet facing disruption ...